{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T23:00:05Z","timestamp":1791932405362,"version":"4.3.4"},"reference-count":29,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1016\/j.vaccine.2011.12.085","type":"journal-article","created":{"date-parts":[[2012,1,3]],"date-time":"2012-01-03T16:02:15Z","timestamp":1325606535000},"page":"1313-1321","source":"Crossref","is-referenced-by-count":16,"title":["Evaluation of attenuated VSVs with mutated M or\/and G proteins as vaccine vectors"],"prefix":"10.1016","volume":"30","author":[{"given":"Xinkui","family":"Fang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shikuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodong","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinjin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.vaccine.2011.12.085_bib0005","doi-asserted-by":"crossref","first-page":"4477","DOI":"10.1073\/pnas.92.10.4477","article-title":"Recombinant vesicular stomatitis viruses from DNA","volume":"92","author":".Lawson","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"issue":"18","key":"10.1016\/j.vaccine.2011.12.085_bib0010","doi-asserted-by":"crossref","first-page":"8388","DOI":"10.1073\/pnas.92.18.8388","article-title":"Efficient recovery of infectious vesicular stomatitis virus entirely from cDNA clones","volume":"92","author":"Whelan","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"21","key":"10.1016\/j.vaccine.2011.12.085_bib0015","doi-asserted-by":"crossref","first-page":"11359","DOI":"10.1073\/pnas.93.21.11359","article-title":"Foreign glycoproteins expressed from recombinant vesicular stomatitis viruses are incorporated efficiently into virus particles","volume":"93","author":".Schnell","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"29-30","key":"10.1016\/j.vaccine.2011.12.085_bib0020","doi-asserted-by":"crossref","first-page":"4035","DOI":"10.1016\/j.vaccine.2004.03.065","article-title":"Recombinant vesicular stomatitis (Indiana) virus expressing New Jersey and Indiana glycoproteins induces neutralizing antibodies to each serotype in swine, a natural host","volume":"22","author":".Martinez","year":"2004","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.vaccine.2011.12.085_bib0025","doi-asserted-by":"crossref","first-page":"5458","DOI":"10.1128\/JVI.78.10.5458-5465.2004","article-title":"Properties of replication-competent vesicular stomatitis virus vectors expressing glycoproteins of filoviruses and arenaviruses","volume":"78","author":"Garbutt","year":"2004","journal-title":"J Virol"},{"issue":"5","key":"10.1016\/j.vaccine.2011.12.085_bib0030","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1099\/vir.0.80844-0","article-title":"A single immunization with a rhabdovirus-based vector expressing severe acute respiratory syndrome coronavirus (SARS-CoV) S protein results in the production of high levels of SARS-CoV-neutralizing antibodies","volume":"86","author":"Faber","year":"2005","journal-title":"J Gen Virol"},{"issue":"14","key":"10.1016\/j.vaccine.2011.12.085_bib0035","doi-asserted-by":"crossref","first-page":"6993","DOI":"10.1128\/JVI.00365-06","article-title":"Evaluating replication-defective vesicular stomatitis virus as a vaccine vehicle","volume":"80","author":".Majid","year":"2006","journal-title":"J Virol"},{"issue":"6","key":"10.1016\/j.vaccine.2011.12.085_bib0040","doi-asserted-by":"crossref","first-page":"4704","DOI":"10.1128\/JVI.72.6.4704-4711.1998","article-title":"Vaccination with a recombinant vesicular stomatitis virus expressing an influenza virus hemagglutinin provides complete protection from influenza virus challenge","volume":"72","author":".Roberts","year":"1998","journal-title":"J Virol"},{"issue":"5","key":"10.1016\/j.vaccine.2011.12.085_bib0045","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S0092-8674(01)00482-2","article-title":"An effective AIDS vaccine based on live attenuated vesicular stomatitis virus recombinants","volume":"106","author":"Rose","year":"2001","journal-title":"Cell"},{"issue":"10","key":"10.1016\/j.vaccine.2011.12.085_bib0050","doi-asserted-by":"crossref","first-page":"6466","DOI":"10.1128\/JVI.69.10.6466-6472.1995","article-title":"Vesicular stomatitis virus infection of the central nervous system activates both innate and acquired immunity","volume":"69","author":"Bi","year":"1995","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2011.12.085_bib0055","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.virol.2006.10.026","article-title":"Neurovirulence properties of recombinant vesicular stomatitis virus vectors in non-human primates","volume":"360","author":"Johnson","year":"2007","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2011.12.085_bib0060","first-page":"1221","article-title":"Rhabdoviridae: the viruses and their replication","author":"Rose","year":"2001"},{"issue":"9","key":"10.1016\/j.vaccine.2011.12.085_bib0065","doi-asserted-by":"crossref","first-page":"5524","DOI":"10.1128\/JVI.77.9.5524-5528.2003","article-title":"The cell-rounding activity of the vesicular stomatitis virus matrix protein is due to the induction of cell death","volume":"77","author":"Kopecky","year":"2003","journal-title":"J Virol"},{"issue":"14","key":"10.1016\/j.vaccine.2011.12.085_bib0070","doi-asserted-by":"crossref","first-page":"8039","DOI":"10.1128\/JVI.77.14.8039-8047.2003","article-title":"Vesicular stomatitis virus glycoprotein is a determinant of pathogenesis in swine, a natural host","volume":"77","author":"Martinez","year":"2003","journal-title":"J Virol"},{"issue":"4","key":"10.1016\/j.vaccine.2011.12.085_bib0075","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1128\/JVI.73.4.2921-2929.1999","article-title":"A proline-rich motif within the matrix protein of vesicular stomatitis virus and rabies virus interacts with WW domains of cellular proteins: implications for viral budding","volume":"73","author":"Harty","year":"1999","journal-title":"J Virol"},{"issue":"9","key":"10.1016\/j.vaccine.2011.12.085_bib0080","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1099\/vir.0.83096-0","article-title":"Modifications of the PSAP region of the matrix protein lead to attenuation of vesicular stomatitis virus in vitro and in vivo","volume":"88","author":"Irie","year":"2007","journal-title":"J Gen Virol"},{"issue":"4","key":"10.1016\/j.vaccine.2011.12.085_bib0085","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S1535-6108(03)00241-1","article-title":"VSV strains with defects in their ability to shutdown innate immunity are potent systemic anti-cancer agents","volume":"4","author":"Stojdl","year":"2003","journal-title":"Cancer Cell"},{"issue":"9","key":"10.1016\/j.vaccine.2011.12.085_bib0090","doi-asserted-by":"crossref","first-page":"3569","DOI":"10.1128\/JVI.63.9.3569-3578.1989","article-title":"Glycoprotein cytoplasmic domain sequences required for rescue of a vesicular stomatitis virus glycoprotein mutant","volume":"63","author":"Whitt","year":"1989","journal-title":"J Virol"},{"issue":"5","key":"10.1016\/j.vaccine.2011.12.085_bib0095","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1093\/emboj\/17.5.1289","article-title":"Requirement for a non-specific glycoprotein cytoplasmic domain sequence to drive efficient budding of vesicular stomatitis virus","volume":"17","author":"Schnell","year":"1998","journal-title":"EMBO J"},{"issue":"1","key":"10.1016\/j.vaccine.2011.12.085_bib0100","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1128\/JVI.67.1.360-365.1993","article-title":"Cytoplasmic domain requirement for incorporation of a foreign envelope protein into vesicular Stomatitis virus","volume":"67","author":"OWENS1","year":"1993","journal-title":"J Virol"},{"issue":"4","key":"10.1016\/j.vaccine.2011.12.085_bib0105","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/sj.cgt.7700794","article-title":"Systemic therapy of experimental breast cancer metastases by mutant vesicular stomatitis virus in immune-competent mice","volume":"12","author":"Ebert","year":"2005","journal-title":"Cancer Gene Ther"},{"issue":"5","key":"10.1016\/j.vaccine.2011.12.085_bib0110","doi-asserted-by":"crossref","first-page":"3723","DOI":"10.1128\/JVI.73.5.3723-3732.1999","article-title":"Attenuated vesicular stomatitis viruses as vaccine vectors","volume":"73","author":"Roberts","year":"1999","journal-title":"J Virol"},{"issue":"5","key":"10.1016\/j.vaccine.2011.12.085_bib0115","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1128\/JVI.01856-06","article-title":"NS1 proteins of avian influenza A viruses can act as antagonists of the human alpha\/beta nterferon response","volume":"81","author":"Hayman","year":"2007","journal-title":"J Virol"},{"issue":"14","key":"10.1016\/j.vaccine.2011.12.085_bib0120","doi-asserted-by":"crossref","first-page":"5259","DOI":"10.1073\/pnas.85.14.5259","article-title":"Homozygous deletion of the alpha- and beta 1-interferon genes in human leukemia and derived cell lines","volume":"85","author":"Diaz","year":"1988","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10.1016\/j.vaccine.2011.12.085_bib0125","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1006\/viro.1998.9508","article-title":"Influenza A virus lacking the NS1 gene replicates in interferon-deficient systems","volume":"252","author":"Garc\u00eda-Sastre","year":"1998","journal-title":"Virology"},{"issue":"13","key":"10.1016\/j.vaccine.2011.12.085_bib0130","doi-asserted-by":"crossref","first-page":"6107","DOI":"10.1128\/JVI.75.13.6107-6114.2001","article-title":"Rearrangement of the genes of vesicular stomatitis virus eliminates clinical disease in the natural host: new strategy for vaccine development","volume":"75","author":"Flanagan","year":"2001","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2011.12.085_bib0135","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.virol.2004.08.039","article-title":"Sensitivity of prostate tumors to wild type and M protein mutant vesicular stomatitis viruses","volume":"330","author":"Ahmed","year":"2004","journal-title":"Virology"},{"issue":"21","key":"10.1016\/j.vaccine.2011.12.085_bib0140","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1093\/jnci\/djj413","article-title":"Effects of intravenously administered recombinant vesicular stomatitis virus (VSV(deltaM51)) on multifocal and invasive gliomas","volume":"98","author":"Lun","year":"2006","journal-title":"J Natl Cancer Inst"},{"issue":"22","key":"10.1016\/j.vaccine.2011.12.085_bib0145","doi-asserted-by":"crossref","first-page":"9010","DOI":"10.1073\/pnas.0901329106","article-title":"Impaired interferon signaling is a common immune defect in human cancer","volume":"106","author":"Critchley-Thorne","year":"2009","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11020342?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11020342?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,29]],"date-time":"2020-06-29T23:50:14Z","timestamp":1593474614000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X11020342"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2]]},"references-count":29,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["S0264410X11020342"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2011.12.085","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,2]]}}}